Eventide Asset Management - Q1 2022 holdings

$6.38 Billion is the total value of Eventide Asset Management's 136 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 16.4% .

 Value Shares↓ Weighting
BHVN  BIOHAVEN PHARMACTL HLDG CO L$193,862,000
-14.0%
1,635,0000.0%3.04%
+5.5%
MTD  METTLER TOLEDO INTERNATIONAL$173,709,000
-19.1%
126,5000.0%2.72%
-0.8%
ASND SellASCENDIS PHARMA A/Ssponsored adr$156,022,000
-33.7%
1,329,432
-24.0%
2.44%
-18.7%
IDXX  IDEXX LABS INC$154,107,000
-16.9%
281,7000.0%2.42%
+1.9%
ROP  ROPER TECHNOLOGIES INC$147,525,000
-4.0%
312,4000.0%2.31%
+17.7%
TTD SellTHE TRADE DESK INC$141,187,000
-29.6%
2,038,800
-6.9%
2.21%
-13.7%
FIVN SellFIVE9 INC$139,049,000
-30.8%
1,259,500
-13.9%
2.18%
-15.1%
NEP  NEXTERA ENERGY PARTNERS LP$138,761,000
-1.2%
1,664,6000.0%2.17%
+21.1%
CRWD SellCROWDSTRIKE HLDGS INCcl a$137,633,000
+9.3%
606,100
-1.5%
2.16%
+34.1%
ODFL  OLD DOMINION FREIGHT LINE IN$132,972,000
-16.7%
445,2000.0%2.08%
+2.2%
ARGX  ARGENX SEsponsored adr$130,065,000
-10.0%
412,5000.0%2.04%
+10.4%
PANW BuyPALO ALTO NETWORKS INC$125,303,000
+48.1%
201,287
+32.4%
1.96%
+81.6%
ZI  ZOOMINFO TECHNOLOGIES INC$124,020,000
-6.9%
2,076,0000.0%1.94%
+14.1%
CTAS  CINTAS CORP$123,193,000
-4.0%
289,6000.0%1.93%
+17.7%
RXDX SellPROMETHEUS BIOSCIENCES INC$122,067,000
-15.9%
3,232,700
-13.6%
1.91%
+3.2%
DLO SellDLOCAL LTD$117,792,000
-24.8%
3,768,149
-14.2%
1.85%
-7.8%
TT BuyTRANE TECHNOLOGIES PLC$113,288,000
-23.5%
741,900
+1.2%
1.78%
-6.2%
DT SellDYNATRACE INC$112,416,000
-32.1%
2,386,741
-12.9%
1.76%
-16.7%
WCN  WASTE CONNECTIONS INC$112,319,000
+2.5%
804,0000.0%1.76%
+25.7%
GNRC BuyGENERAC HLDGS INC$110,610,000
-14.6%
372,100
+1.1%
1.73%
+4.7%
ENTG BuyENTEGRIS INC$108,526,000
+8.8%
826,800
+14.9%
1.70%
+33.4%
POOL  POOL CORP$104,486,000
-25.3%
247,1000.0%1.64%
-8.4%
EXAS  EXACT SCIENCES CORP$104,181,000
-10.2%
1,490,0000.0%1.63%
+10.1%
HUBS SellHUBSPOT INC$103,885,000
-34.5%
218,733
-9.1%
1.63%
-19.7%
KNBE BuyKNOWBE4 INCcl a$96,960,000
+46.5%
4,211,983
+45.9%
1.52%
+79.6%
LRCX  LAM RESEARCH CORP$96,956,000
-25.2%
180,3460.0%1.52%
-8.3%
KRTX  KARUNA THERAPEUTICS INC$94,839,000
-3.2%
748,0000.0%1.49%
+18.7%
LOW SellLOWES COS INC$89,142,000
-32.5%
440,884
-13.7%
1.40%
-17.2%
GH BuyGUARDANT HEALTH INC$86,966,000
-1.9%
1,312,900
+48.2%
1.36%
+20.3%
APTV BuyAPTIV PLC$86,155,000
-2.7%
719,700
+34.0%
1.35%
+19.3%
GLBE BuyGLOBAL E ONLINE LTD$84,294,000
-37.9%
2,495,391
+16.6%
1.32%
-23.8%
SPT BuySPROUT SOCIAL INC$84,121,000
-6.9%
1,049,943
+5.4%
1.32%
+14.2%
DHI SellD R HORTON INC$79,092,000
-31.9%
1,061,500
-0.9%
1.24%
-16.6%
DDOG BuyDATADOG INC$74,978,000
-13.9%
495,000
+1.2%
1.18%
+5.6%
ASML SellASML HOLDING N V$68,530,000
-44.2%
102,600
-33.5%
1.07%
-31.6%
TREX  TREX CO INC$64,677,000
-51.6%
990,0000.0%1.01%
-40.7%
CCI  CROWN CASTLE INTL CORP NEW$61,509,000
-11.6%
333,2000.0%0.96%
+8.4%
COUR BuyCOURSERA INC$57,351,000
+35.0%
2,489,174
+43.2%
0.90%
+65.6%
MPWR BuyMONOLITHIC PWR SYS INC$57,236,000
+36.2%
117,848
+38.4%
0.90%
+67.0%
CWEN BuyCLEARWAY ENERGY INCcl c$55,853,000
+4.5%
1,529,800
+3.1%
0.88%
+28.1%
BCYC  BICYCLE THERAPEUTICS PLCsponsored ads$55,441,000
-27.9%
1,263,4710.0%0.87%
-11.6%
A BuyAGILENT TECHNOLOGIES INC$54,308,000
-9.6%
410,400
+9.1%
0.85%
+10.8%
COLL  COLLEGIUM PHARMACEUTICAL INC$53,539,000
+9.0%
2,629,5930.0%0.84%
+33.6%
BEP  BROOKFIELD RENEWABLE PARTNERpartnership unit$50,763,000
+14.8%
1,236,0000.0%0.80%
+40.7%
CLDX BuyCELLDEX THERAPEUTICS INC NEW$49,241,000
+2.9%
1,445,700
+16.7%
0.77%
+26.1%
PRAX BuyPRAXIS PRECISION MEDICINES I$44,873,000
-40.2%
4,395,000
+15.3%
0.70%
-26.7%
REXR BuyREXFORD INDL RLTY INC$44,530,000
+85.9%
597,000
+102.1%
0.70%
+128.1%
XMTR BuyXOMETRY INC$44,102,000
-9.8%
1,200,052
+25.8%
0.69%
+10.6%
HASI SellHANNON ARMSTRONG SUST INFR C$43,183,000
-24.1%
910,464
-15.0%
0.68%
-6.9%
TSM  TAIWAN SEMICONDUCTOR MFG LTDsponsored ads$42,747,000
-13.3%
410,0000.0%0.67%
+6.3%
LNG BuyCHENIERE ENERGY INC$40,541,000
+506.5%
292,400
+343.7%
0.64%
+647.1%
NOVT  NOVANTA INC$39,841,000
-19.3%
280,0000.0%0.62%
-1.1%
MDB  MONGODB INCcl a$39,637,000
-16.2%
89,3550.0%0.62%
+2.8%
SMAR BuySMARTSHEET INC$38,182,000
-27.3%
697,000
+2.8%
0.60%
-10.9%
BPMC BuyBLUEPRINT MEDICINES CORP$37,849,000
-10.7%
592,500
+49.7%
0.59%
+9.4%
MRTX BuyMIRATI THERAPEUTICS INC$37,310,000
-12.8%
453,781
+55.6%
0.58%
+6.9%
VRSK SellVERISK ANALYTICS INC$35,435,000
-27.3%
165,100
-22.5%
0.56%
-10.9%
 DICE THERAPEUTICS INC$35,202,000
-23.1%
1,871,6120.0%0.55%
-5.6%
ZYME BuyZYMEWORKS INC$35,240,000
-23.7%
5,380,200
+90.8%
0.55%
-6.4%
ZNTL BuyZENTALIS PHARMACEUTICALS INC$35,113,000
-21.0%
761,000
+43.9%
0.55%
-3.2%
BEPC  BROOKFIELD RENEWABLE CORPcl a sub vtg$33,946,000
+18.9%
775,0190.0%0.53%
+45.8%
KURA BuyKURA ONCOLOGY INC$33,142,000
+73.9%
2,061,044
+51.4%
0.52%
+113.6%
NVT BuyNVENT ELECTRIC PLC$30,697,000
-2.9%
882,600
+6.1%
0.48%
+19.1%
IMVT BuyIMMUNOVANT INC$29,603,000
-29.8%
5,372,512
+8.5%
0.46%
-13.9%
COGT BuyCOGENT BIOSCIENCES INC$29,211,000
-3.1%
3,900,000
+11.0%
0.46%
+19.0%
ADCT  ADC THERAPEUTICS SA$29,013,000
-27.3%
1,975,0000.0%0.46%
-10.8%
ENPH BuyENPHASE ENERGY INC$29,070,000
+138.9%
144,069
+116.6%
0.46%
+193.5%
LSCC  LATTICE SEMICONDUCTOR CORP$28,753,000
-20.9%
471,7440.0%0.45%
-3.0%
CGNX  COGNEX CORP$27,697,000
-0.8%
359,0000.0%0.43%
+21.6%
STE BuySTERIS PLC$27,123,000
+13.7%
112,185
+14.5%
0.42%
+39.3%
VITL SellVITAL FARMS INC$27,069,000
-49.2%
2,190,051
-25.8%
0.42%
-37.7%
PLD BuyPROLOGIS INC.$26,999,000
-0.1%
167,200
+4.1%
0.42%
+22.3%
MASS  908 DEVICES INC$26,804,000
-26.5%
1,410,0000.0%0.42%
-9.9%
NRIX  NURIX THERAPEUTICS INC$26,199,000
-51.6%
1,870,0000.0%0.41%
-40.8%
EPIX BuyESSA PHARMA INC$25,772,000
-45.3%
4,170,259
+25.7%
0.40%
-32.9%
KLAC BuyKLA CORP$24,683,000
+0.6%
67,428
+18.2%
0.39%
+23.6%
 DUOLINGO INC$24,491,000
-10.4%
257,5000.0%0.38%
+10.0%
SNPS BuySYNOPSYS INC$24,348,000
+44.4%
73,057
+59.7%
0.38%
+77.2%
ISRG  INTUITIVE SURGICAL INC$22,626,000
-16.0%
75,0000.0%0.36%
+3.2%
RGEN  REPLIGEN CORP$22,383,000
-29.0%
119,0000.0%0.35%
-12.9%
STRO  SUTRO BIOPHARMA INC$22,268,000
-44.8%
2,708,9750.0%0.35%
-32.2%
YETI SellYETI HLDGS INC$22,133,000
-66.7%
369,000
-54.0%
0.35%
-59.2%
NDAQ BuyNASDAQ INC$22,097,000
-0.7%
124,000
+17.0%
0.35%
+21.8%
NBIX  NEUROCRINE BIOSCIENCES INC$22,031,000
+10.1%
235,0000.0%0.34%
+34.8%
WMB BuyWILLIAMS COS INC$21,853,000
+190.5%
654,100
+126.4%
0.34%
+256.2%
ESI BuyELEMENT SOLUTIONS INC$21,265,000
-6.2%
971,000
+4.0%
0.33%
+14.8%
SNDX  SYNDAX PHARMACEUTICALS INC$20,248,000
-20.6%
1,165,0000.0%0.32%
-2.8%
PNR BuyPENTAIR PLC$18,995,000
-20.4%
350,400
+7.2%
0.30%
-2.3%
CCXI SellCHEMOCENTRYX INC$18,261,000
-51.8%
728,385
-30.0%
0.29%
-40.9%
FRC BuyFIRST REP BK SAN FRANCISCO C$17,572,000
-10.3%
108,400
+14.2%
0.28%
+10.0%
ELS  EQUITY LIFESTYLE PPTYS INC$17,453,000
-12.8%
228,2000.0%0.27%
+6.6%
SNV SellSYNOVUS FINL CORP$17,116,000
-6.9%
349,300
-9.0%
0.27%
+14.0%
NewNCINO INC$17,056,000416,200
+100.0%
0.27%
 PALO ALTO NETWORKS INCnote 0.750% 7/0$15,956,000
+11.6%
6,810,0000.0%0.25%
+36.6%
WD NewWALKER & DUNLOP INC$15,781,000121,935
+100.0%
0.25%
 GXO LOGISTICS INCORPORATED$15,695,000
-21.5%
220,0000.0%0.25%
-3.5%
TALS  TALARIS THERAPEUTICS INC$15,361,000
-35.6%
1,561,0920.0%0.24%
-21.0%
CGEM  CULLINAN ONCOLOGY INC$15,078,000
-30.4%
1,440,1450.0%0.24%
-14.8%
AESC BuyAES CORPunit 99/99/9999$14,948,000
+26.0%
151,100
+22.2%
0.23%
+53.9%
WEC NewWEC ENERGY GROUP INC$14,512,000145,400
+100.0%
0.23%
XNCR SellXENCOR INC$13,360,000
-34.2%
500,755
-1.0%
0.21%
-19.3%
SYY BuySYSCO CORP$13,170,000
+27.6%
161,298
+22.8%
0.21%
+56.1%
ICPT BuyINTERCEPT PHARMACEUTICALS IN$13,016,000
+144.0%
800,000
+144.3%
0.20%
+200.0%
APTVPRA NewAPTIV PLC5.5% cnv pfd a$12,932,00094,500
+100.0%
0.20%
VCYT SellVERACYTE INC$11,524,000
-57.0%
418,000
-35.8%
0.18%
-47.2%
IEX  IDEX CORP$11,197,000
-18.9%
58,4000.0%0.18%
-0.6%
TRGP NewTARGA RES CORP$11,071,000146,700
+100.0%
0.17%
VECT  VECTIVBIO HLDG AG$10,994,000
-1.7%
2,339,0440.0%0.17%
+20.3%
SHLS SellSHOALS TECHNOLOGIES GROUP INcl a$10,579,000
-76.4%
620,832
-66.4%
0.17%
-71.0%
EGP BuyEASTGROUP PPTYS INC$10,327,000
+50.1%
50,800
+68.2%
0.16%
+84.1%
ANNX BuyANNEXON INC$9,900,000
-69.8%
3,626,508
+27.2%
0.16%
-62.9%
XPO SellXPO LOGISTICS INC$8,372,000
-50.9%
115,000
-47.7%
0.13%
-39.9%
BuyROIVANT SCIENCES LTD$8,177,000
+22.0%
1,690,300
+141.5%
0.13%
+48.8%
GRMN  GARMIN LTD$7,235,000
-12.9%
61,0000.0%0.11%
+6.6%
LOB SellLIVE OAK BANCSHARES INC$6,971,000
-70.0%
136,983
-48.5%
0.11%
-63.3%
WMS  ADVANCED DRAIN SYS INC DEL$6,900,000
-12.7%
58,0780.0%0.11%
+6.9%
ARE BuyALEXANDRIA REAL ESTATE EQ IN$6,782,000
+42.8%
33,700
+58.2%
0.11%
+73.8%
DSGN  DESIGN THERAPEUTICS INC$6,460,000
-24.6%
400,0000.0%0.10%
-7.3%
PHVS BuyPHARVARIS N V$5,659,000
+46.0%
302,619
+23.6%
0.09%
+78.0%
MNDY NewMONDAY COM LTD$5,137,00032,500
+100.0%
0.08%
IMGN  IMMUNOGEN INC$4,760,000
-35.8%
1,000,0000.0%0.08%
-21.1%
KBH  KB HOME$4,588,000
-27.6%
141,7000.0%0.07%
-11.1%
PHAT  PHATHOM PHARMACEUTICALS INC$4,576,000
-30.8%
336,2230.0%0.07%
-15.3%
SHW  SHERWIN WILLIAMS CO$4,618,000
-29.1%
18,5000.0%0.07%
-13.3%
NewENPHASE ENERGY INCnote 3/0$4,554,0004,463,000
+100.0%
0.07%
FOUR SellSHIFT4 PMTS INCcl a$4,335,000
-15.9%
70,000
-21.3%
0.07%
+3.0%
FRLN BuyFREELINE THERAPEUTICS HLDGSsponsored ads$3,970,000
-41.2%
3,606,192
+3.5%
0.06%
-27.9%
CRDF SellCARDIFF ONCOLOGY INC$3,640,000
-63.7%
1,467,922
-12.1%
0.06%
-55.5%
OM  OUTSET MED INC$3,133,000
-1.5%
69,0000.0%0.05%
+19.5%
SLAB  SILICON LABORATORIES INC$2,874,000
-27.2%
19,1370.0%0.04%
-10.0%
CIEN SellCIENA CORP$2,607,000
-89.1%
43,000
-86.1%
0.04%
-86.6%
BuyARTERIS INC$2,522,000
-33.7%
194,000
+7.6%
0.04%
-18.4%
BRKS SellAZENTA INC$2,462,000
-62.6%
29,700
-53.5%
0.04%
-53.6%
BOLT SellBOLT BIOTHERAPEUTICS INC$2,356,000
-66.8%
859,826
-40.7%
0.04%
-59.3%
 GUARDANT HEALTH INCnote 11/1$2,341,000
-20.6%
2,900,0000.0%0.04%
-2.6%
ETTX  ENTASIS THERAPEUTICS HLDGS I$1,104,000
-14.6%
590,6020.0%0.02%0.0%
PLRX ExitPLIANT THERAPEUTICS INC$0-42,499
-100.0%
-0.01%
ALLK ExitALLAKOS INC$0-90,084
-100.0%
-0.01%
ExitPLANET LABS PBC$0-155,000
-100.0%
-0.01%
KALV ExitKALVISTA PHARMACEUTICALS INC$0-138,821
-100.0%
-0.02%
ExitEXACT SCIENCES CORPnote 0.375% 3/0$0-3,815,000
-100.0%
-0.05%
NEE ExitNEXTERA ENERGY INC$0-47,900
-100.0%
-0.06%
SBAC ExitSBA COMMUNICATIONS CORP NEWcl a$0-13,200
-100.0%
-0.07%
AWK ExitAMERICAN WTR WKS CO INC NEW$0-34,100
-100.0%
-0.08%
AQNU ExitALGONQUIN PWR UTILS CORPunit 99/99/9999$0-140,800
-100.0%
-0.08%
ETNB Exit89BIO INC$0-716,670
-100.0%
-0.12%
COMP ExitCOMPASS INCcl a$0-1,110,899
-100.0%
-0.13%
SBNY ExitSIGNATURE BK NEW YORK N Y$0-48,750
-100.0%
-0.20%
APTVPRA ExitAPTIV PLC5.5% cnv pfd a added$0-87,500
-100.0%
-0.21%
MAX ExitMEDIAALPHA INCcl a$0-1,098,246
-100.0%
-0.22%
NCNO ExitNCINO INC$0-688,000
-100.0%
-0.48%
MGA ExitMAGNA INTL INC$0-764,400
-100.0%
-0.79%
W ExitWAYFAIR INCcl a$0-334,477
-100.0%
-0.81%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-16
Signatures

The EDGAR filing(s) were signed by:

About Eventide Asset Management

Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.

The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.

The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.

Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.

Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LOWES COS INC40Q3 20233.2%
PALO ALTO NETWORKS INC40Q3 20233.6%
ASML HOLDINGS NV40Q3 20231.9%
NEUROCRINE BIOSCIENCES INC40Q3 20231.1%
REPLIGEN CORP40Q3 20230.5%
VERACYTE INC38Q3 20231.5%
LAM RESEARCH CORP35Q3 20233.4%
XPO LOGISTICS INC34Q1 20233.8%
COLLEGIUM PHARMACEUTICAL INC34Q3 20232.6%
MAGNA INTL INC33Q4 20212.5%

View Eventide Asset Management's complete holdings history.

Latest significant ownerships (13-D/G)
Eventide Asset Management Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cogent Biosciences, Inc.February 14, 20232,589,7783.7%
ESSA Pharma Inc.Sold outFebruary 14, 202300.0%
Freeline Therapeutics Holdings plcFebruary 14, 20235,920,7659.1%
KnowBe4, Inc.Sold outFebruary 14, 202300.0%
Praxis Precision Medicines, Inc.February 14, 20233,518,0627.5%
Prometheus Biosciences, Inc.February 14, 20231,032,9382.2%
SUTRO BIOPHARMA, INC.Sold outFebruary 14, 202300.0%
Vital Farms, Inc.Sold outFebruary 14, 202300.0%
Zymeworks Inc.Sold outFebruary 14, 202300.0%
Entasis Therapeutics Holdings Inc.February 14, 2022590,6021.2%

View Eventide Asset Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-02-20
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Eventide Asset Management's complete filings history.

Compare quarters

Export Eventide Asset Management's holdings